
Natera NTRA
$ 195.12
-2.52%
Quarterly report 2024-Q3
added 11-12-2024
Natera Depreciation & Amortization 2011-2026 | NTRA
Annual Depreciation & Amortization Natera
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.7 M | 11.3 M | 8.61 M | 7.73 M | 7.5 M | 7.14 M | 6.18 M | 5.54 M | 5.15 M | 2.53 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.7 M | 2.53 M | 7.83 M |
Quarterly Depreciation & Amortization Natera
| 2024-Q3 | 2023-Q4 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 3 M | - | - | - | 2.55 M | - | 6.22 M | 4.04 M | 1.83 M | - | 5.92 M | 3.95 M | 1.92 M | - | 5.57 M | 3.68 M | 1.86 M | - | 5.32 M | 3.62 M | 1.76 M | - | 4.18 M | 2.43 M | 1.19 M | - | 4.36 M | 2.97 M | 1.64 M | - | 3.67 M | 2.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.22 M | 1.19 M | 3.36 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Agilent Technologies
A
|
321 M | $ 110.97 | -3.4 % | $ 33.7 B | ||
|
Castle Biosciences
CSTL
|
16 M | $ 23.96 | -3.0 % | $ 666 M | ||
|
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Neogen Corporation
NEOG
|
119 M | $ 9.07 | -2.94 % | $ 1.97 B | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
1.11 M | $ 1.53 | -6.13 % | $ 2.04 M | ||
|
Personalis
PSNL
|
10.9 M | $ 5.05 | -8.27 % | $ 299 M | ||
|
CareDx, Inc
CDNA
|
15 M | $ 20.44 | -6.71 % | $ 1.09 B | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
24.9 M | $ 14.79 | -3.33 % | $ 447 M | ||
|
Illumina
ILMN
|
354 M | $ 120.84 | -4.79 % | $ 19.2 B | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 163.54 | -1.9 % | $ 8.11 B | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Twist Bioscience Corporation
TWST
|
24.9 M | $ 56.8 | -3.97 % | $ 3.4 B | ||
|
Guardant Health
GH
|
39.7 M | $ 82.48 | -0.77 % | $ 10.3 B | ||
|
Lantheus Holdings
LNTH
|
70.1 M | $ 81.06 | -2.98 % | $ 5.47 B | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
425 K | $ 1.99 | 2.9 % | $ 8.8 M | ||
|
Senseonics Holdings
SENS
|
1.51 M | $ 6.44 | -10.31 % | $ 269 M | ||
|
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 411.04 | 0.31 % | $ 11.9 B | ||
|
Biomerica
BMRA
|
87 K | $ 2.16 | -1.22 % | $ 4.96 M | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
488 M | $ 116.7 | 13.86 % | $ 9.63 B | ||
|
Laboratory Corporation of America Holdings
LH
|
681 M | $ 256.03 | -1.35 % | $ 21.3 B | ||
|
NeoGenomics
NEO
|
36.1 M | $ 8.98 | -0.5 % | $ 1.15 B | ||
|
Celcuity
CELC
|
167 K | $ 118.45 | -1.35 % | $ 5.54 B | ||
|
National Research Corporation
NRC
|
7.62 M | $ 16.04 | -4.78 % | $ 359 M | ||
|
Myriad Genetics
MYGN
|
53.7 M | $ 4.68 | -3.41 % | $ 433 M | ||
|
Quest Diagnostics Incorporated
DGX
|
570 M | $ 189.26 | -2.93 % | $ 21 B | ||
|
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M | ||
|
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 16.55 | -0.6 % | $ 178 M | ||
|
OpGen
OPGN
|
175 K | - | -16.95 % | $ 1.54 M | ||
|
Organovo Holdings
ONVO
|
266 K | - | -2.3 % | $ 19.4 M |